Dual Role of Insulin-Like Growth Factor (IGF)-I in American Tegumentary Leishmaniasis

Table 2

Area of expression of insulin-like growth factor (IGF)-I in the lesions of cutaneous leishmaniasis patients according to the duration of illness and response to treatment.

	Groups	IGF-I-area %
		Median
Duration of illness	Early lesion ()	1.47		0.023
	Intermediate ()	1.50
	Late lesion ()	3.12
Treatment response	Good responder ()	2.10		^#0.03
	Poor response ()	1.05

Spearman correlation, ^#Mann-Whitney test.